Skip to content
Clinical Trials – home
Research site

Centrum Diagnostyczno Lecznicze Barska Sp. z o.o.

Poland Ul. Barska 13, 87-800 Wloclawek, Poland

  • 1 trial recruiting
  • Colitis ulcerative · Crohn's disease
  • Adult patients

About Specializations

Centrum Diagnostyczno Lecznicze Barska Sp. z o.o. in Wloclawek, Poland specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, and other specialisations. This site conducts important research.

Main research areas of the site

Digestive System Diseases

The department concentrates on innovative approaches for ulcerative colitis, a chronic inflammatory disorder of the colon.

  • Oral small‑molecule therapy (NX‑13) evaluation
  • Comparison of IV biologic PB016 with established therapy Entyvio®

At Centrum Diagnostyczno Lecznicze Barska, investigators are testing new medications to improve disease control and assess safety, aiming to broaden treatment options for patients with moderate to severe ulcerative colitis.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Barska 1387-800 WloclawekPoland
Recruiting now
1 trial
Conditions studied
2

More sites in WloclawekPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

10 clinical trials

Colitis ulcerative+1

Recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bi 3032950
  • Sponsor:Boehringer Ingelheim International GmbH

Crohn's disease

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Prometheus Biosciences Inc.

Colitis ulcerative

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Eclitasertib
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Vedolizumab
  • Sponsor:Polpharma Biologics S.A.

Colitis ulcerative

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:1,3,5-Tris(6-Methylpyridin-2-Yloxy)Benzene
  • Sponsor:Landos Biopharma Inc.

Crohn's disease

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Golimumab
  • Sponsor:Janssen - Cilag International

Colitis ulcerative

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Golimumab
  • Sponsor:Janssen - Cilag International
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.